- Forbes•5 hours ago
Juliana Keeping tried petitioning Vertex CEO Jeffrey Leiden to lower the price of his company's cystic fibrosis drug. Now she's ratcheting up her fight against the company.
- Investor's Business Daily•22 hours ago
Vertex remains ahead of Galapagos in developing a triple of drugs to treat cystic fibrosis, RBC analyst Michael Yee said Thursday.
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||78.75 x 300|
|Ask||78.86 x 100|
|Day's Range||74.95 - 79.30|
|52wk Range||74.95 - 134.71|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-84.85|
|Avg Vol (3m)||1,485,060|
|Dividend & Yield||N/A (N/A)|